Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.

@article{Ehsan2015ManagementOP,
  title={Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.},
  author={Zarmina Ehsan and John P Clancy},
  journal={Future microbiology},
  year={2015},
  volume={10 12},
  pages={1901-12}
}
Pseudomonas aeruginosa (PsA) is a highly prevalent bacterial organism recovered from the lungs of cystic fibrosis (CF) patients and chronic PsA infection is linked to progressive pulmonary function decline. The eradication and treatment of this organism from CF airways is particularly challenging to CF care providers. Aerosolized antibiotics that target PsA help to slow down growth, maintain lung function and reduce the frequency of pulmonary exacerbations. In this review, we discuss the… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Bacteria in the respiratory tract-how to treat? Or do not treat?

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases • 2016

Similar Papers

Loading similar papers…